Parexel discusses transdermal drug delivery techs
Electroporation is the wave of the future for transdermal drug delivery, according to Parexel’s Ravi Harapanhalli.
Archives for December 22, 2011
Pall to buy ForteBio to build biopharma biz
Pall will buy US instrument maker ForteBio next year in a continuation of efforts to build its biomanufacturing technology offering.
Amgen and Watson team on biosimilars but agree to spare Amgen's drugs
Amgen has partnered with non-branded drugmaker Watson to develop biosimilar cancer drugs in a deal that goes some way towards protecting its own portfolio from generic competition.